1.Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.Abubakar, Mustapha; Orr, Nick; Daley, Frances; Coulson, Penny; Ali, H Raza; Blows, Fiona; Benitez, Javier; Milne, Roger;Brenner, Herman; Stegmaier, Christa; Mannermaa, Arto; Chang-Claude, Jenny; Rudolph, Anja; Sinn, Peter; Couch, Fergus J; Devilee, Peter; Tollenaar, Rob A E M; Seynaeve, Caroline; Figueroa, Jonine; Sherman, Mark E; Lissowska, Jolanta; Hewitt, Stephen; Eccles, Diana; Hooning, Maartje J; Hollestelle, Antoinette; Martens, John W M; van Deurzen, Carolien H M; Investigators, kConFab; Bolla, Manjeet K; Wang, Qin; Jones, Michael; Schoemaker, Minouk; Wesseling, Jelle; van Leeuwen, Flora E; Van 't Veer, Laura; Easton, Douglas; Swerdlow, Anthony J; Dowsett, Mitch; Pharoah, Paul D;Schmidt, Marjanka K; Garcia-Closas, Montserrat.Breast Cancer Res; 18(1): 104, 2016 Oct 18.2.CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer.Dai, Meiou; Zhang, Chenjing; Ali, Ayad; Hong, Xinyuan; Tian, Jun; Lo, Chieh; Fils-Aime, Nadege; Burgos, Sergio A; Ali, Suhad; Lebrun, Jean-Jacques.Sci Rep; 6: 35383, 2016 Oct 19.3.The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?Jerzak, Katarzyna J; Pritchard, Kathleen I.Eur J Cancer; 68: 173-175, 2016 Oct 18.4.Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.Hrebien, Sarah; O'Leary, Ben; Beaney, Matthew; Schiavon, Gaia; Fribbens, Charlotte; Bhambra, Amarjit; Johnson, Richard; Garcia-Murillas, Isaac; Turner, Nicholas.PLoS One; 11(10): e0165023, 2016.5.Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.Ehinger, Anna; Malmstrom, Per; Bendahl, Par-Ola; Elston, Christopher W; Falck, Anna-Karin; Forsare, Carina; Grabau, Dorthe; Ryden, Lisa; Stal, Olle; Ferno, Marten.Acta Oncol; : 1-7, 2016 Oct 20.6.Prognostic Value of E-Cadherin and -Catenin in Triple-Negative Breast Cancer.Shen, Tiansheng; Zhang, Kui; Siegal, Gene P; Wei, Shi.Am J Clin Pathol; 2016 Oct 25.7.Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.Rakha, Emad A; Agarwal, Devika; Green, Andrew R; Ashankyty, Ibraheem; Ellis, Ian O; Ball, Graham; Alaskandarany, Mohammed A.Histopathology; 2016 Oct 26.8.Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation.Meng, Liwei; Xu, Yingchun; Xu, Chaoyang; Zhang, Wei.Onco Targets Ther; 9: 6177-6185, 2016.9.Current advances in biomarkers for targeted therapy in triple-negative breast cancer.Fleisher, Brett; Clarke, Charlotte; Ait-Oudhia, Sihem.Breast Cancer (Dove Med Press); 8: 183-197, 2016.10.Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.Furrer, Daniela; Lemieux, Julie; Cote, Marc-Andre; Provencher, Louise; Laflamme, Christian; Barabe, Frederic; Jacob, Simon; Michaud, Annick; Diorio, Caroline.Breast; 30: 191-196, 2016 Oct 24.11.The analytical validation of the Oncotype DX Recurrence Score assay.Baehner, Frederick L.Ecancermedicalscience; 10: 675, 2016.12.Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems.Choi, Misun; Park, Yeon Hee; Ahn, Jin Seok; Im, Young-Hyuck; Nam, Seok Jin; Cho, Soo Youn; Cho, Eun Yoon.Breast Cancer Res Treat; 2016 Oct 11.13.Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Beije, Nick; Onstenk, Wendy; Kraan, Jaco; Sieuwerts, Anieta M; Hamberg, Paul; Dirix, Luc Y; Brouwer, Anja; de Jongh,